Strides Arcolab Gets FDA OK For Sumatriptan Succinate Injection

14th Jun 2010 14:12

MUMBAI (Dow Jones)--Strides Arcolab Ltd. (532531.BY) said Monday it has received approval from the U.S. Food and Drug Administration to sell the generic sumatriptan succinate injection. Sumatriptan succinate, a copycat version of GlaxoSmithKline PLC's (GSK) Imitrex, is used to treat migraine. The Indian drug maker said the product will be launched in the U.S. shortly and will be marketed by Sagent Pharmaceuticals. -By Satish Sarangarajan, Dow Jones Newswires; +91 22 6145 6120; [email protected] (END) Dow Jones Newswires June 14, 2010 09:12 ET (13:12 GMT)

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.